Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neurofibromatosis 1 × Radiation × CNS × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 79 Brain Neoplasms 33 Gliosarcoma 29 Glioma 24 Astrocytoma 18 Central Nervous System Neoplasms 11 Medulloblastoma 9 Oligodendroglioma 5 Neuroblastoma 5 Ganglioneuroblastoma 5 Ependymoma 4 Diffuse Intrinsic Pontine Glioma 4 Neoplasms 3 Breast Neoplasms 3 Meningeal Carcinomatosis 2 Melanoma 2 Untreated Childhood Anaplastic Astrocytoma 1 Squamous Cell Carcinoma of Head and Neck 1 Spinal Cord Neoplasms 1 Sarcoma 1 Salivary Gland Neoplasms 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Retinoblastoma 1 Recurrence 1 Rare Diseases 1 Prostatic Neoplasms 1 Pinealoma 1 Obesity 1 Neurofibromatosis 1 1

Interventions

AZD 6244 19 trametinib 5 Lovastatin 5 Deoxycholic Acid 4 mirdametinib 3 Lasers, Solid-State 3 pirfenidone 2 fludarabine 2 binimetinib 2 Vincristine 2 Vinblastine 2 Transcranial Direct Current Stimulation 2 Specimen Handling 2 Sirolimus 2 Polidocanol 2 Magnetic Resonance Spectroscopy 2 Magnetic Resonance Imaging 2 Lasers 2 Lamotrigine 2 Inhalation 2 Everolimus 2 Carboplatin 2 Blood Specimen Collection 2 Biopsy 2 Acetylcysteine 2 tipifarnib 1 thymoglobulin 1 talimogene laherparepvec 1 pomalidomide 1 peginterferon alfa-2b 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07521657 2026-04-13

NF118

University of Alabama at Birmingham

Phase 2 Not yet recruiting

Glioblastoma, Glioma, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡